12th Annual UCSF Spine Symposium is organized by University of California, San Francisco School of Medicine (UCSF) Continuing Medical Education and would be held during Jun 2 - 3, 2016 at Hilton San Francisco Financial District, San Francisco, California, United States of America. This CME conference has been approved with a maximum of 12.75 AMA PRA Category 1 Credits.
The UCSF Spine Symposium is an annual two day event emphasizing pioneering trends in diagnostic and therapeutic strategies for patients suffering from spinal disorders. This course is designed to be interactive with talks given by leaders in the spine community. All lectures are followed by case discussions aimed at highlighting key issues in breakthrough treatments. The course is designed for neurosurgeons, orthopedists, nurses, physical therapists, physiatrists, anesthesiologists, pain specialists as well as primary care providers.
Objectives:
The purpose of this course is to increase competence and improve clinical practice in the management of patients with spinal pathologies. Attendees will be better equipped to:
• Evaluate and treat spinal pain in a cost effective and reliable manner based on recently published guidelines;
• Identify appropriate indications for surgery of the painful, degenerated spine and identify the appropriate surgical approach in the painful, degenerative spinal conditions based on recently published guidelines;
• Evaluate and treat lumbar degenerative disease and deformity in a cost effective manner and avoid perioperative complications by identifying risk factors that may predispose to morbidity;
• Determine the most appropriate pain management strategies for patients with spine-related pain;
• Increase utilization and competence with NASS spinal stenosis guidelines;
• Provide physical exams that include a process to identify lower extremity pain that dissipates while sitting and exacerbates with standing or walking;
• Identify spinal instability related to spinal tumors and formulate surgical treatment plans to deal with neurological deficits and pain in spine oncology patients based on recently published guidelines.